Skip to content
PDRN Care
WikiBiochemistry

Nucleotide Salvage Pathway

Dr. Sarah Chen

Dr. Sarah Chen

PhD, Molecular Biology

4 minMarch 27, 2026

The nucleotide salvage pathway is one of two mechanisms by which PDRN exerts its regenerative effects on skin tissue. While the adenosine A2A receptor pathway handles the signaling side — telling cells to regenerate — the salvage pathway handles the metabolic supply side, providing cells with the raw materials they need to actually carry out DNA replication and repair.

Two Ways to Make Nucleotides

Cells need nucleotides (the building blocks of DNA and RNA) for replication, repair, and normal function. There are two metabolic routes to obtain them [3]:

De Novo Synthesis

The de novo pathway builds nucleotides from scratch, starting from simple metabolic precursors: amino acids (glutamine, glycine, aspartate), CO₂, and tetrahydrofolate cofactors. This is an energy-expensive, multi-enzyme process requiring 6–10 enzymatic steps for each nucleotide. It consumes significant ATP and is metabolically costly, particularly for cells that are dividing rapidly or repairing extensive DNA damage.

Salvage Pathway

The salvage pathway recycles pre-formed nucleotide components — free bases (purines and pyrimidines) and nucleosides — back into active nucleotides. This is a metabolically efficient shortcut that requires only 1–2 enzymatic steps and significantly less ATP than de novo synthesis [3][4]. The salvage pathway is the preferred route in most tissues, accounting for 80–90% of nucleotide production in non-dividing cells.

How PDRN Feeds the Salvage Pathway

PDRN (polydeoxyribonucleotide) consists of fragmented double-stranded DNA chains with molecular weights of 50–1,500 kDa. When PDRN is administered to tissue (injected or applied topically), extracellular nucleases progressively degrade these DNA fragments into smaller oligonucleotides, nucleosides, and free bases [1][2].

These degradation products — deoxyadenosine, deoxyguanosine, deoxycytidine, and thymidine (nucleosides), along with their corresponding free bases — are taken up by surrounding cells through nucleoside transporters and base transporters in the cell membrane. Once inside the cell, salvage enzymes convert them directly into active nucleotide triphosphates (dATP, dGTP, dCTP, dTTP) — the immediate substrates for DNA polymerase [1].

The key salvage enzymes include:

  • Thymidine kinase — Converts thymidine to thymidine monophosphate (dTMP)
  • Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) — Converts hypoxanthine and guanine to their corresponding nucleotides
  • Adenine phosphoribosyltransferase (APRT) — Converts adenine to adenosine monophosphate

Why This Matters for Skin Regeneration

The salvage pathway is especially important for actively dividing cells — fibroblasts proliferating in response to growth factor signals or A2A receptor activation, keratinocytes turning over in the epidermis, and endothelial cells forming new blood vessels [2]. These cells have dramatically increased DNA synthesis requirements:

  • A single cell division requires the synthesis of approximately 6 billion nucleotides to replicate the entire human genome
  • DNA repair from UV damage requires a continuous supply of nucleotides to replace damaged bases through excision repair pathways
  • Rapidly dividing cells can deplete local nucleotide pools faster than de novo synthesis alone can replenish them

By providing a rich supply of pre-formed nucleotide building blocks, PDRN effectively removes a metabolic bottleneck in tissue regeneration. Cells stimulated to divide and repair (whether by PDRN's own A2A signaling, by growth factors from other treatments, or by wound healing responses) can access the nucleotides they need immediately through the salvage pathway rather than waiting for the slower de novo synthesis [1].

The Dual Mechanism of PDRN

This is what makes PDRN's mechanism uniquely comprehensive compared to other regenerative ingredients [2]:

  1. A2A receptor pathway (signaling): The adenosine released from PDRN degradation activates A2A receptors, sending the biological signal to "regenerate" — proliferate, make collagen, form new blood vessels, suppress inflammation.
  2. Salvage pathway (substrate supply): The nucleotide fragments from the same PDRN degradation provide the metabolic raw materials cells need to execute those regenerative instructions — DNA building blocks for cell division and repair.

Most other regenerative ingredients only provide one half of this equation. Growth factors and peptides send signals but do not provide metabolic substrates. Metabolic supplements provide substrates but do not activate specific regenerative signaling cascades. PDRN does both simultaneously, which is a key reason it produces clinically measurable improvements in tissue regeneration across multiple outcome measures.

Clinical Relevance

The salvage pathway mechanism explains several clinically observed properties of PDRN:

  • Accelerated wound healing — Wounds treated with PDRN heal faster because both the regenerative signals and the metabolic fuel for repair are delivered together [1]
  • Synergy with other treatments — PDRN enhances outcomes when combined with lasers, microneedling, or chemical peels because it supplies nucleotides to cells that are already dividing rapidly in response to the controlled injury
  • Dose-dependent effects — Higher concentrations of PDRN provide more nucleotide substrate, supporting more robust regenerative responses up to the cells' capacity ceiling
  • Broad tissue benefit — The salvage pathway is active in all nucleated cells, which is why PDRN benefits multiple cell types (fibroblasts, keratinocytes, endothelial cells) rather than targeting only one
Reviewed by Dr. Min-Ji Park, MD, Board-Certified Dermatologist

References

  1. [1]
    Bitto A, Polito F, Irrera N, et al.. Polydeoxyribonucleotide: a potential new approach for tissue repair. Expert Opinion on Biological Therapy. 2013;13(2):165-172. doi:10.1517/14712598.2012.741129
  2. [2]
    Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Current Pharmaceutical Design. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  3. [3]
    Nyhan WL. Nucleotide Synthesis via Salvage Pathway. Encyclopedia of Life Sciences. 2005. doi:10.1038/npg.els.0003918
  4. [4]
    Murray AW. The Biological Significance of Purine Salvage. Annual Review of Biochemistry. 1971;40:811-826. doi:10.1146/annurev.bi.40.070171.004115
ShareTwitterLinkedIn

Search

Search across products, blog posts, wiki articles, and more.